Takeda Pharmaceutical (TAK) Cash & Current Investments: 2017-2025

Historic Cash & Current Investments for Takeda Pharmaceutical (TAK) over the last 9 years, with Mar 2025 value amounting to $2.7 billion.

  • Takeda Pharmaceutical's Cash & Current Investments fell 16.69% to $2.7 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $17.6 billion, marking a year-over-year decrease of 27.96%. This contributed to the annual value of $2.7 billion for FY2025, which is 18.80% down from last year.
  • As of FY2025, Takeda Pharmaceutical's Cash & Current Investments stood at $2.7 billion, which was down 18.80% from $3.3 billion recorded in FY2024.
  • Over the past 5 years, Takeda Pharmaceutical's Cash & Current Investments peaked at $9.5 billion during FY2021, and registered a low of $2.7 billion during FY2025.
  • Over the past 3 years, Takeda Pharmaceutical's median Cash & Current Investments value was $3.3 billion (recorded in 2024), while the average stood at $3.3 billion.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 57.35% in 2021, then slumped by 47.41% in 2023.
  • Takeda Pharmaceutical's Cash & Current Investments (Yearly) stood at $9.5 billion in 2021, then declined by 17.61% to $7.8 billion in 2022, then tumbled by 47.41% to $4.1 billion in 2023, then dropped by 20.00% to $3.3 billion in 2024, then declined by 18.80% to $2.7 billion in 2025.